We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The topic of quantum computing just keeps on cropping up. There doesn’t seem to be any sector that isn’t enthralled by the potential that the quantum revolution will bring – and pharma is no different.
Quantum computing technology uses quantum systems called “qubits”. They work with non-binary values, unlike classical computing which uses only bits with values of 0 or 1, and can overlap each other and act as a group.
German pharma company Boehringer Ingelheim has signed a collaborative agreement with Google Quantum AI to research and implement quantum computing in pharma research and development.